Please try another search
| YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|
| Growth of 1000 | 1048 | 1016 | 1186 | 1394 | 1570 | 2340 |
| Fund Return | 4.76% | 1.62% | 18.6% | 11.7% | 9.44% | 8.87% |
| Place in category | 547 | 455 | 540 | 570 | 418 | 172 |
| % in Category | 20 | 19 | 24 | 30 | 26 | 16 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| NL0011225305 | 7.08B | 7.32 | 15.85 | 11.77 | ||
| NL0011515424 | 5.65B | 28.80 | 21.82 | 9.05 | ||
| NL0013552078 | 2.29B | 4.43 | 8.31 | - | ||
| Northern Trust RE UCITS FGR C EUR | 293.99M | -1.89 | 3.10 | - |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| NL0010948220 | 3.02B | 12.03 | 13.58 | 9.58 | ||
| ACTIAM Responsible Index Fund EU | 1.07B | 13.43 | 17.13 | 9.47 | ||
| NN Europe Fund P | 267.36M | 9.49 | 15.10 | 9.44 | ||
| S Horizon European Growth Fund H1 E | -4.26 | 7.43 | 7.11 | |||
| ACTIAM Responsible Index Fund EquiA | 91.89M | -0.12 | 14.86 | 13.33 |
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| ASML Holding | NL0010273215 | 4.21 | 1,260.80 | +1.94% | |
| HSBC | GB0005405286 | 2.38 | 1,292.20 | -2.09% | |
| AstraZeneca | GB0009895292 | 2.22 | 13,646.0 | -1.13% | |
| Roche Holding Participation | CH1499059983 | 2.16 | 403.40 | -0.69% | |
| Novartis | CH0012005267 | 2.13 | 131.48 | -1.35% |
| Type | Daily | Weekly | Monthly |
|---|---|---|---|
| Moving Averages | Buy | Buy | Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review